Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Peter V Jenkins"'
Autor:
Marcela Rosas, David A Slatter, Samya G Obaji, Jason P Webber, Jorge Alvarez-Jarreta, Christopher P Thomas, Maceler Aldrovandi, Victoria J Tyrrell, Peter V Jenkins, Valerie B O'Donnell, Peter W Collins
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0240189 (2020)
Tissue factor (TF) is critical for the activation of blood coagulation. TF function is regulated by the amount of externalised phosphatidylserine (PS) and phosphatidylethanolamine (PE) on the surface of the cell in which it is expressed. We investiga
Externí odkaz:
https://doaj.org/article/663339f647e04721afa1ed9dca10d61e
Autor:
Lucy de Lloyd, Peter V. Jenkins, Sarah F. Bell, Nicola J. Mutch, Julia Freyer Martins Pereira, Pilar M. Badenes, Donna James, Anouk Ridgeway, Leon Cohen, Thomas Roberts, Victoria Field, Rachel E. Collis, Peter W. Collins
Publikováno v:
Journal of Thrombosis and Haemostasis. 21:862-879
Autor:
Peter V. Jenkins
Publikováno v:
Research and Practice in Thrombosis and Haemostasis
Autor:
Peter V. Jenkins, Samya Obaji, Christopher P. Thomas, Marcela Rosas, Jason P. Webber, Jorge Alvarez-Jarreta, Peter William Collins, Valerie B. O'Donnell, David A. Slatter, Maceler Aldrovandi, Victoria J. Tyrrell
Publikováno v:
PLoS ONE
PLoS ONE, Vol 15, Iss 10, p e0240189 (2020)
PLoS ONE, Vol 15, Iss 10, p e0240189 (2020)
Tissue factor (TF) is critical for the activation of blood coagulation. TF function is regulated by the amount of externalised phosphatidylserine (PS) and phosphatidylethanolamine (PE) on the surface of the cell in which it is expressed. We investiga
Publikováno v:
Blood. 104:256-256
Type 1 von Willebrand disease (VWD) is a heterogeneous bleeding disorder in which genetic modifying factors, including ABO blood group, contribute towards the variability in von Willebrand factor (VWF) levels. Recent findings have reported an increas